Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05202418 · ClinicalTrials.gov registry record · NA
Stress in Inflammatory Bowel Disease
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT05202418 is a NA study that has completed, run by Emory University. The registered enrollment target is 53 participants.
The verdict
NCT05202418, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
This is a prospective, assessment-based study to examine the relationship between psychophysiological functioning and psychological symptoms in youth newly diagnosed with inflammatory bowel disease (IBD) compared to healthy controls.
Interventions
- BEHAVIORAL Biofeedback Enhanced Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2022-02-27 |
| Est. Completion | 2024-01-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05202418
The ClinicalTrials.gov registry entry for NCT05202418 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biofeedback Enhanced Treatment is the first listed.
NCT05202418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05202418 about?
NCT05202418 is a clinical study titled "Stress in Inflammatory Bowel Disease". This is a prospective, assessment-based study to examine the relationship between psychophysiological functioning and psychological symptoms in youth newly diagnosed with inflammatory bowel disease (IBD) compared to healthy controls.
What is the current status of trial NCT05202418?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2022-02-27. Estimated completion is 2024-01-13.
What interventions are being tested in trial NCT05202418?
The interventions under investigation include: Biofeedback Enhanced Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05202418?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.